Haoran Xia

Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

Junjie Hu, Lele Zhang, Haoran Xia et al. · Genome Medicine · 2023 · 380 citations · Full text

Medicine, Immunology, Oncology +17

Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer

Yilv Yan, Dongqing Sun, Junjie Hu et al. · Nature Genetics · 2024 · 130 citations

Medicine, Bioinformatics, Oncology +14

Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial

Xinsheng Zhu, Liangdong Sun, Nan Song et al. · BMC Medicine · 2022 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer

Peng Zhang, Jie Dai, Fenghuan Sun et al. · The Annals of Thoracic Surgery · 2022 · 59 citations

Medicine, Oncology, Chemotherapy +11

Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study

Dongliang Bian, Liangdong Sun, Junjie Hu et al. · Nature Communications · 2023 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17